Business, energy, technology, markets and global industry news from Business News Today

XIAFLEX

Pharma & Biotech

Can XIAFLEX straighten hammer toe without surgery? Keenova begins pivotal US trial

Keenova has dosed the first patient in a randomized Phase 3 study evaluating whether collagenase injections can reduce fixed toe contracture and provide a nonsurgical treatment for hammer toe.

Read More
Pharma & Biotech

XIAFLEX hit its Phase 3 goals, but can Keenova change plantar fibromatosis care?

Find out how Keenova’s XIAFLEX Phase 3 success could create the first approved drug for plantar fibromatosis.

Read More